Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Teva Pharmaceuticals USA

ClinicalTrials.gov Identifier:

NCT01686152

First received: September 12, 2012

Last updated: December 5, 2013

Last verified: December 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2013
Primary Completion Date:	August 2013 (Final data collection date for primary outcome measure)